Eagle Pharmaceuticals (EGRX) Financial Statements

214 Followers

Eagle Pharmaceuticals Financial Overview

Eagle Pharmaceuticals's market cap is currently $7.73M. The company's EPS TTM is $1.19; its P/E ratio is 0.02; Eagle Pharmaceuticals is scheduled to report earnings on May 11, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Income Statement
Total Revenue	$ 316.61M	$ 171.55M	$ 187.80M	$ 195.89M	$ 213.31M
Gross Profit	$ 221.67M	$ 129.37M	$ 142.34M	$ 135.00M	$ 151.40M
Operating Income	$ 80.96M	$ 2.77M	$ 32.95M	$ 21.82M	$ 36.62M
EBITDA	$ 77.50M	$ 847.00K	$ 30.02M	$ 29.34M	$ 40.44M
Net Income	$ 35.64M	$ -8.63M	$ 11.99M	$ 14.31M	$ 31.90M
Balance Sheet
Cash & Short-Term Investments	$ 55.32M	$ 97.66M	$ 103.16M	$ 109.78M	$ 78.79M
Total Assets	$ 406.16M	$ 253.73M	$ 253.19M	$ 254.55M	$ 238.60M
Total Debt	$ 67.79M	$ 29.82M	$ 38.22M	$ 38.56M	$ 44.41M
Net Debt	$ 12.47M	$ -72.05M	$ -66.06M	$ -71.22M	$ -34.39M
Total Liabilities	$ 172.60M	$ 77.28M	$ 67.18M	$ 75.38M	$ 77.84M
Stockholders' Equity	$ 233.56M	$ 176.45M	$ 186.01M	$ 179.17M	$ 160.76M
Cash Flow
Free Cash Flow	$ 50.52M	$ 27.90M	$ 48.75M	$ 55.21M	$ 52.25M
Operating Cash Flow	$ 50.70M	$ 28.22M	$ 49.50M	$ 55.99M	$ 52.38M
Investing Cash Flow	$ -86.83M	$ -5.32M	$ -18.25M	$ -777.00K	$ -133.00K
Financing Cash Flow	$ -6.21M	$ -28.39M	$ -37.87M	$ -24.23M	$ -88.12M

Currency in USD

Eagle Pharmaceuticals Earnings and Revenue History

Income Statement >

Eagle Pharmaceuticals Debt to Assets

Balance Sheet >

Eagle Pharmaceuticals Cash Flow

Cash Flow >

Eagle Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >